Cyclacel Pharmaceuticals, Inc. (CYCC) SEC filings
CYCC SEC filings moved a median of -1.38% by the close. CYCC SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the CYCC overview →
117 measured CYCC SEC filing events.
Where these CYCC SEC filings landedvs 112 measured CYCC SEC filing reactions
| Middle 50% of CYCC SEC filing reactions | -5.24% to +2.34% |
|---|---|
| Median reaction (to close) | -1.38% |
| Measured reactions | 112 |
Point-in-time · zero look-ahead
Half of the 112 CYCC SEC filing events with a measured close landed between -5.24% and +2.34%; 38% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K/A Bio Green Med Solution, For: Sep 12 | SEC filing · Form 8-K | — | — | |
| Form 8-K Bio Green Med Solution, For: Sep 12 | SEC filing · Form 8-K | — | — | |
| Form 8-K Cyclacel Pharmaceuticals For: Sep 12 | SEC filing · Form 8-K | — | — | |
| Form EFFECT Cyclacel Pharmaceuticals | SEC filing · Form EFFECT | — | — | |
| Form 8-K Cyclacel Pharmaceuticals For: Sep 04 | SEC filing · Form 8-K | +1.74% | +3.49% | |
| Form 8-K Cyclacel Pharmaceuticals For: Sep 04 | SEC filing · Form 8-K | +0.00% | -3.52% | |
| Form 8-K Cyclacel Pharmaceuticals For: Sep 01 | SEC filing · Form 8-K | -0.49% | -5.18% | |
| Form POS AM Cyclacel Pharmaceuticals | SEC filing · Form POS | -0.49% | -5.18% | |
| Form 8-K Cyclacel Pharmaceuticals For: Aug 22 | SEC filing · Form 8-K | -2.60% | -2.98% | |
| Form DEFA14A Cyclacel Pharmaceuticals | SEC filing · Form DEFA14A | — | +0.53% | |
| Form POS AM Cyclacel Pharmaceuticals | SEC filing · Form POS | +0.75% | -0.13% | |
| Form 10-Q Cyclacel Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | +1.77% | +1.95% | |
| Form 8-K Cyclacel Pharmaceuticals For: Aug 12 | SEC filing · Form 8-K | +2.94% | -1.22% | |
| Form 8-K Cyclacel Pharmaceuticals For: Aug 13 | SEC filing · Form 8-K | +1.77% | +1.95% | |
| Form EFFECT Cyclacel Pharmaceuticals | SEC filing · Form EFFECT | -5.48% | -22.40% | |
| Form S-1/A Cyclacel Pharmaceuticals | SEC filing · Form S-1 | -3.21% | -7.66% | |
| Form 8-K Cyclacel Pharmaceuticals For: Jul 28 | SEC filing · Form 8-K | +2.01% | — | |
| Form EFFECT Cyclacel Pharmaceuticals | SEC filing · Form EFFECT | +0.03% | -2.22% | |
| Form POS AM Cyclacel Pharmaceuticals | SEC filing · Form POS | +1.41% | -7.20% | |
| Form S-1 Cyclacel Pharmaceuticals | SEC filing · Form S-1 | +1.41% | -7.20% | |
| Form S-4 Cyclacel Pharmaceuticals | SEC filing · Form S-4 | +1.41% | -7.20% | |
| Form S-8 POS Cyclacel Pharmaceuticals | SEC filing · Form S-8 | +1.41% | -7.20% | |
| Form 8-K Cyclacel Pharmaceuticals For: Jul 15 | SEC filing · Form 8-K | -2.67% | -12.02% | |
| Form 8-K Cyclacel Pharmaceuticals For: Jul 07 | SEC filing · Form 8-K | -13.01% | -8.93% | |
| Form DEF 14C Cyclacel Pharmaceuticals For: Jul 07 | SEC filing · Form DEF | -0.92% | +1.21% | |
| Form 8-K Cyclacel Pharmaceuticals For: Jul 02 | SEC filing · Form 8-K | -17.88% | -14.52% | |
| Form 8-K Cyclacel Pharmaceuticals For: Jun 30 | SEC filing · Form 8-K | -3.08% | +0.39% | |
| Form DEFA14A Cyclacel Pharmaceuticals | SEC filing · Form DEFA14A | +2.39% | -1.47% | |
| Form PRE 14C Cyclacel Pharmaceuticals For: Jun 25 | SEC filing · Form PRE | +0.73% | +2.27% | |
| Form 8-K Cyclacel Pharmaceuticals For: Jun 20 | SEC filing · Form 8-K | +1.36% | -0.85% | |
| Form 8-K Cyclacel Pharmaceuticals For: Jun 03 | SEC filing · Form 8-K | -1.24% | -10.49% | |
| Form DEF 14C Cyclacel Pharmaceuticals For: May 23 | SEC filing · Form DEF | +1.39% | +12.50% | |
| Form 8-K Cyclacel Pharmaceuticals For: May 14 | SEC filing · Form 8-K | +0.79% | -4.76% | |
| Form 10-Q Cyclacel Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | +1.00% | -5.58% | |
| Form PRE 14C Cyclacel Pharmaceuticals For: May 13 | SEC filing · Form PRE | -10.11% | -16.25% | |
| Form 8-K Cyclacel Pharmaceuticals For: May 07 | SEC filing · Form 8-K | -0.03% | -6.44% | |
| Form 8-K Cyclacel Pharmaceuticals For: May 06 | SEC filing · Form 8-K | +0.00% | +9.69% | |
| Form EFFECT Cyclacel Pharmaceuticals | SEC filing · Form EFFECT | -2.78% | +3.99% | |
| Form 8-K Cyclacel Pharmaceuticals For: Apr 25 | SEC filing · Form 8-K | -2.95% | -4.45% | |
| Form S-1 Cyclacel Pharmaceuticals | SEC filing · Form S-1 | -10.86% | -1.14% | |
| Form DEF 14A Cyclacel Pharmaceuticals For: Apr 24 | SEC filing · Form DEF | — | -0.78% | |
| Form 8-K Cyclacel Pharmaceuticals For: Apr 21 | SEC filing · Form 8-K | +1.74% | -8.22% | |
| Form S-8 Cyclacel Pharmaceuticals | SEC filing · Form S-8 | +1.74% | -8.22% | |
| Form DEF 14C Cyclacel Pharmaceuticals For: Apr 03 | SEC filing · Form DEF | +2.27% | -2.73% | |
| Form 10-K Cyclacel Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | +0.00% | -4.17% | |
| Form 8-K Cyclacel Pharmaceuticals For: Mar 31 | SEC filing · Form 8-K | +0.00% | -4.17% | |
| Form NT 10-K Cyclacel Pharmaceuticals For: Dec 31 | SEC filing · Form NT | -1.05% | +0.87% | |
| Form D Cyclacel Pharmaceuticals | SEC filing · Form D | — | +0.33% | |
| Form 8-K Cyclacel Pharmaceuticals For: Mar 21 | SEC filing · Form 8-K | +0.00% | +5.13% | |
| Form PRE 14C Cyclacel Pharmaceuticals For: Mar 24 | SEC filing · Form PRE | -1.28% | +6.26% | |
| Form 8-K Cyclacel Pharmaceuticals For: Mar 10 | SEC filing · Form 8-K | +3.27% | +1.02% | |
| Form 8-K Cyclacel Pharmaceuticals For: Feb 26 | SEC filing · Form 8-K | +0.38% | -2.79% | |
| Form 8-K Cyclacel Pharmaceuticals For: Feb 20 | SEC filing · Form 8-K | +0.00% | -1.91% | |
| Form D Cyclacel Pharmaceuticals | SEC filing · Form D | -1.73% | -5.41% | |
| Form 8-K Cyclacel Pharmaceuticals For: Feb 06 | SEC filing · Form 8-K | -0.06% | +5.74% | |
| Form 8-K Cyclacel Pharmaceuticals For: Feb 04 | SEC filing · Form 8-K | +0.00% | -4.24% | |
| Form 8-K Cyclacel Pharmaceuticals For: Jan 31 | SEC filing · Form 8-K | -1.20% | -1.38% | |
| Form DEF 14A Cyclacel Pharmaceuticals For: Feb 06 | SEC filing · Form DEF | +2.46% | -0.30% | |
| Form 8-K Cyclacel Pharmaceuticals For: Jan 09 | SEC filing · Form 8-K | -0.98% | +2.56% | |
| Form PRER14A Cyclacel Pharmaceuticals | SEC filing · Form PRER14A | -1.81% | -4.40% | |
| Form PRE 14A Cyclacel Pharmaceuticals For: Jan 07 | SEC filing · Form PRE | -2.10% | +1.44% | |
| Form 8-K Cyclacel Pharmaceuticals For: Jan 02 | SEC filing · Form 8-K | -2.05% | +12.50% | |
| Form 8-K Cyclacel Pharmaceuticals For: Dec 06 | SEC filing · Form 8-K | -0.11% | -1.45% | |
| Form D Cyclacel Pharmaceuticals | SEC filing · Form D | +0.58% | +3.21% | |
| Form 8-K Cyclacel Pharmaceuticals For: Nov 13 | SEC filing · Form 8-K | -2.90% | -4.91% | |
| Form 10-Q Cyclacel Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | +6.21% | +8.22% | |
| Form 8-K Cyclacel Pharmaceuticals For: Nov 05 | SEC filing · Form 8-K | +6.21% | +8.22% | |
| Form 8-K Cyclacel Pharmaceuticals For: Nov 12 | SEC filing · Form 8-K | +6.21% | +8.22% | |
| Form RW Cyclacel Pharmaceuticals | SEC filing · Form RW | +8.32% | -7.74% | |
| Form 8-K Cyclacel Pharmaceuticals For: Oct 22 | SEC filing · Form 8-K | -3.53% | -2.12% | |
| Form S-1 Cyclacel Pharmaceuticals | SEC filing · Form S-1 | -4.51% | -10.33% | |
| Form 8-K Cyclacel Pharmaceuticals For: Sep 04 | SEC filing · Form 8-K | +0.00% | +2.80% | |
| Form 8-K Cyclacel Pharmaceuticals For: Aug 29 | SEC filing · Form 8-K | -1.92% | +1.15% | |
| Form 8-K Cyclacel Pharmaceuticals For: Aug 22 | SEC filing · Form 8-K | -3.98% | -4.92% | |
| Form 8-K Cyclacel Pharmaceuticals For: Aug 19 | SEC filing · Form 8-K | +1.70% | +3.38% | |
| Form 10-Q Cyclacel Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | +0.70% | -7.69% | |
| Form 8-K Cyclacel Pharmaceuticals For: Aug 14 | SEC filing · Form 8-K | +0.70% | -7.69% | |
| Form S-8 Cyclacel Pharmaceuticals | SEC filing · Form S-8 | +1.89% | +0.00% | |
| Form 8-K Cyclacel Pharmaceuticals For: Jun 21 | SEC filing · Form 8-K | +4.19% | -4.79% | |
| Form D Cyclacel Pharmaceuticals | SEC filing · Form D | -4.52% | -4.52% | |
| Form 10-Q Cyclacel Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | -3.92% | -13.17% | |
| Form 8-K Cyclacel Pharmaceuticals For: May 14 | SEC filing · Form 8-K | -3.92% | -13.17% | |
| Form EFFECT Cyclacel Pharmaceuticals | SEC filing · Form EFFECT | +1.35% | +27.93% | |
| Form ARS Cyclacel Pharmaceuticals For: Dec 31 | SEC filing · Form ARS | -0.30% | +8.92% | |
| Form DEF 14A Cyclacel Pharmaceuticals For: Jun 21 | SEC filing · Form DEF | -0.30% | +8.92% | |
| Form DEFA14A Cyclacel Pharmaceuticals | SEC filing · Form DEFA14A | -0.30% | +8.92% | |
| Form S-1 Cyclacel Pharmaceuticals | SEC filing · Form S-1 | -2.41% | +1.93% | |
| Form 8-K Cyclacel Pharmaceuticals For: Apr 30 | SEC filing · Form 8-K | +2.53% | -15.61% | |
| Form 10-K/A Cyclacel Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | -6.74% | +9.85% | |
| Form RW Cyclacel Pharmaceuticals | SEC filing · Form RW | -6.74% | +9.85% | |
| Form 8-K Cyclacel Pharmaceuticals For: Apr 26 | SEC filing · Form 8-K | +2.27% | +3.03% | |
| Form S-1/A Cyclacel Pharmaceuticals | SEC filing · Form S-1 | +5.90% | -10.11% | |
| Form S-1/A Cyclacel Pharmaceuticals | SEC filing · Form S-1 | -1.67% | -2.78% | |
| Form 8-K Cyclacel Pharmaceuticals For: Mar 27 | SEC filing · Form 8-K | +1.41% | -6.82% | |
| Form S-1 Cyclacel Pharmaceuticals | SEC filing · Form S-1 | -0.29% | -1.38% | |
| Form 10-K Cyclacel Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | +0.00% | +4.69% | |
| Form 8-K Cyclacel Pharmaceuticals For: Mar 19 | SEC filing · Form 8-K | -1.29% | -3.44% | |
| Form EFFECT Cyclacel Pharmaceuticals | SEC filing · Form EFFECT | -1.61% | +3.25% | |
| Form S-1/A Cyclacel Pharmaceuticals | SEC filing · Form S-1 | -1.27% | -1.70% | |
| Form 8-K Cyclacel Pharmaceuticals For: Jan 25 | SEC filing · Form 8-K | -0.94% | +3.74% | |
| Form S-1 Cyclacel Pharmaceuticals | SEC filing · Form S-1 | +0.00% | +4.03% | |
| Form 8-K Cyclacel Pharmaceuticals For: Jan 12 | SEC filing · Form 8-K | -0.51% | -5.11% | |
| Form 8-K Cyclacel Pharmaceuticals For: Jan 08 | SEC filing · Form 8-K | -3.69% | +10.63% | |
| Form 8-K Cyclacel Pharmaceuticals For: Jan 04 | SEC filing · Form 8-K | +1.50% | -1.97% | |
| Form 8-K Cyclacel Pharmaceuticals For: Dec 21 | SEC filing · Form 8-K | +4.82% | -1.06% | |
| Form 8-K Cyclacel Pharmaceuticals For: Dec 08 | SEC filing · Form 8-K | -6.67% | -9.70% | |
| Cyclacel Regains Compliance With Nasdaq Listing Rule Following Filing of Its Form 10-Q With the SEC | Press release | -3.78% | -10.07% | |
| Form 10-K/A Cyclacel Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | +0.00% | -1.00% | |
| Form 10-Q Cyclacel Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -1.00% | |
| Cyclacel Receives Notification of Deficiency From Nasdaq Regarding Timely Filing of Quarterly Report on Form 10-Q | Press release | +0.00% | -1.00% | |
| Form 8-K Cyclacel Pharmaceuticals For: Nov 21 | SEC filing · Form 8-K | +0.00% | -1.00% | |
| Form 8-K Cyclacel Pharmaceuticals For: Nov 14 | SEC filing · Form 8-K | +2.29% | +0.29% | |
| Form NT 10-Q Cyclacel Pharmaceuticals For: Sep 30 | SEC filing · Form NT | +2.29% | +0.29% | |
| Form DEF 14A Cyclacel Pharmaceuticals For: Dec 08 | SEC filing · Form DEF | -2.53% | +1.76% | |
| Form 8-K Cyclacel Pharmaceuticals For: Nov 13 | SEC filing · Form 8-K | +0.02% | -32.90% | |
| Form 8-K Cyclacel Pharmaceuticals For: Nov 02 | SEC filing · Form 8-K | -4.45% | -4.81% | |
| Form PRE 14A Cyclacel Pharmaceuticals For: Dec 14 | SEC filing · Form PRE | -1.80% | +3.73% |
Keep exploring
More CYCC: earnings → · analyst actions → · CYCC overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| MeiraGTx Holdings plc - Ordinary Shares (MGTX) | 239 | -0.10% | 46% |
| Ovid Therapeutics Inc. (OVID) | 239 | -0.32% | 40% |
| RESTORBIO (TORC) | 238 | -0.17% | 46% |
| Retractable Technologies, Inc. (RVP) | 237 | 0.00% | 45% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.